CAH · Consumer

CARDINAL HEALTH INC

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-07

Regulatory RiskImportance 37 · Surprise 42
Cardinal Health is facing questions about quality controls after nationwide recalls of certain levothyroxine tablet lots by a Cardinal-affiliated distributor. The recalls could generate recall-related costs and require…
Product Safety RecallImportance 31 · Surprise 42
Nationwide recalls affected certain levothyroxine tablet lots distributed by a Cardinal-affiliated distributor. The recalls have raised questions about Cardinal Health’s quality controls and product-integrity…
Pharmaceutical Specialty DemandImportance 26 · Surprise 24
Analysts expect Cardinal Health’s Pharmaceutical and Specialty Solutions business to be the primary driver of stronger fourth-quarter performance. Demand is described as favorable for specialty healthcare services,…
Competition and Market ShareImportance 17 · Surprise 24
Cardinal Health, McKesson, and Cencora collectively control more than 90% of the U.S. drug distribution market, indicating a highly concentrated domestic wholesaling structure. Cencora’s specialty assets are reportedly…

Competition and Market ShareImportance 17 · Surprise 24
Cardinal Health, McKesson, and Cencora collectively control more than 90% of the U.S. drug distribution market, indicating a highly concentrated domestic wholesaling structure. Cencora’s specialty assets are reportedly…

Competition and Market ShareImportance 17 · Surprise 24
Cardinal Health, McKesson, and Cencora collectively control more than 90% of the U.S. drug distribution market, indicating a highly concentrated domestic wholesaling structure. Cencora’s specialty assets are reportedly…

Competition and Market ShareImportance 17 · Surprise 24
Cardinal Health, McKesson, and Cencora collectively control more than 90% of the U.S. drug distribution market, indicating a highly concentrated domestic wholesaling structure. Cencora’s specialty assets are reportedly…